RYMAN HEALTHCARE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.71 NZD | -0.27% |
|
0.00% | -37.12% |
| May. 27 | Transcript : Ryman Healthcare Limited, 2024 Earnings Call, May 27, 2024 | |
| May. 26 | Ryman Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Evolution of the average Target Price on Ryman Healthcare Limited
Price target over the last 5 years
History of analyst recommendation changes
ed69.o6NrT34d2FWNnq16kUQwl1auvtlVYx-MQS0oY4f2sTk.7e8zBVN7jyHArs8O2gJgxRiZ9Og8VnnkNHd9NtCn2HXg8TM1K2fgN8bd5A~f1921dc4df6862606f6575a0509c7b94
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.71
NZD
Average target price
6.048
NZD
Spread / Average Target
+63.02%
High Price Target
7.25
NZD
Spread / Highest target
+95.42%
Low Price Target
4.04
NZD
Spread / Lowest Target
+8.89%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Ryman Healthcare Limited
| Jarden Research | |
| UBS |
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- RYM Stock
- Consensus Ryman Healthcare Limited
